Healthcare
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Trend Stats
1-Month Return
-2.39%
3-Month Return
+11.20%
12-Month Return
+28.76%
Volatility Score
1.3
RSI
55.5
ST Trend
Neutral
LT Trend
Up
Short-Term Trend
Neutral
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Healthcare
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1.1T | +66.44% | +5.94% | -5.22% | 2.5 | Neutral | Up |
| JNJ | Johnson&Johnson | $652B | +55.73% | +12.87% | -0.38% | 1.9 | Neutral | Up |
| ABBV | AbbVie | $468B | +25.08% | +13.67% | +0.23% | 2.0 | Up | Up |
| MRK | Merck | $365B | +96.30% | +23.43% | -1.20% | 2.2 | Up | Up |
| UNH | Unitedhealth Gro | $337B | +11.41% | -7.02% | -5.38% | 2.5 | Down | Up |
| TMO | Thermo Fisher Sc | $251B | +48.25% | +37.93% | +7.98% | 2.2 | Up | Up |
| AMGN | Amgen | $220B | +53.88% | +16.21% | -8.52% | 2.6 | Neutral | Up |
| GILD | Gilead Sciences | $186B | +38.20% | +20.27% | +2.58% | 2.3 | Up | Up |
| ABT | Abbott Laborator | $175B | -22.43% | +12.49% | -13.37% | 2.5 | Down | Down |
| PFE | Pfizer | $162B | +28.82% | +20.25% | +1.57% | 1.8 | Up | Up |
| DHR | Danaher | $157B | +24.23% | +18.72% | +4.03% | 2.5 | Up | Up |
| ISRG | Intuitive Surgic | $141B | -8.81% | -0.57% | +6.95% | 2.7 | Up | Down |
| VRTX | Vertex Pharma | $132B | +36.80% | +9.93% | -4.60% | 2.2 | Neutral | Up |
| BMY | Bristol-MyersSqu | $126B | +48.47% | +13.08% | -8.59% | 2.0 | Down | Up |
| MDT | Medtronic | $113B | -3.09% | +11.45% | -4.73% | 2.5 | Down | Neutral |
| CVS | CVS Health | $109B | +17.61% | -15.99% | -9.63% | 2.5 | Down | Down |
| SYK | Stryker | $103B | -26.07% | -13.78% | -17.71% | 3.4 | Down | Down |
| MCK | Mckesson | $101B | +18.50% | +13.53% | -0.40% | 2.4 | Down | Up |
| HCA | HCA Healthcare | $92B | +2.77% | +9.41% | -1.16% | 3.1 | Up | Down |
| ELV | Elevance Health | $86B | +28.25% | +4.16% | -0.66% | 2.6 | Neutral | Up |
| REGN | Regeneron Pharma | $82B | +44.03% | +27.83% | -3.92% | 2.5 | Neutral | Up |
| MRNA | MODERNA | $78B | +691.63% | +222.44% | +40.27% | 6.0 | Up | Up |
| CI | The Cigna | $70B | -4.42% | -4.47% | -4.81% | 2.3 | Down | Down |
| BSX | Boston Scientifi | $65B | -54.47% | +0.49% | -8.83% | 3.6 | Down | Down |
| COR | Cencora | $59B | +4.49% | +9.14% | -4.29% | 2.2 | Down | Down |
| CAH | Cardinal Health | $52B | +51.00% | -4.25% | -4.20% | 2.2 | Down | Neutral |
| EW | Edwards Lifescns | $49B | +13.90% | -4.38% | -5.27% | 2.4 | Down | Neutral |
| BDX | Becton Dickinson | $49B | +1.73% | +22.01% | -5.48% | 2.2 | Neutral | Up |
| A | Agilent Tech | $49B | +42.94% | +31.56% | +12.65% | 2.9 | Up | Up |
| HUM | Humana | $46B | +51.64% | +5.41% | -1.63% | 3.3 | Down | Up |
| IQV | IQVIA Holdings | $45B | +55.65% | +48.16% | +5.68% | 2.5 | Up | Up |
| VEEV | Veeva Systems-A | $44B | -1.82% | +70.34% | +10.62% | 3.8 | Up | Up |
| WAT | Waters | $42B | +49.52% | +16.56% | +4.76% | 2.7 | Up | Up |
| ILMN | Illumina | $41B | +197.10% | +56.43% | +22.70% | 4.0 | Up | Up |
| IDXX | IDEXX Labs | $40B | -16.95% | -6.51% | -8.24% | 2.5 | Down | Down |
| BIIB | Biogen | $33B | +66.85% | +13.41% | +3.78% | 2.5 | Up | Up |
| DXCM | Dexcom | $33B | +28.07% | +25.41% | -3.94% | 2.7 | Neutral | Up |
| RMD | Resmed | $32B | -16.11% | +13.25% | -4.54% | 2.7 | Neutral | Down |
| CNC | Centene | $31B | +80.05% | -1.67% | -5.68% | 3.8 | Down | Up |
| MTD | Mettler Toledo I | $30B | +25.60% | +26.26% | +8.60% | 2.6 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |
